Parian Global Management LP Aspira Women'S Health Inc. Transaction History

Parian Global Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $5.85 Million - $10 Million	-1,833,059 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.78 - $6.84 $3.2 Million - $4.58 Million	-668,990 Reduced 26.74%	1,833,059 $10.3 Million
Q1 2021 May 17, 2021	BUY	$5.9 - $9.13 $14.8 Million - $22.8 Million	2,502,049 New	2,502,049 $16.9 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Parian Global Management LP with notifications on news.